학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 55건 | 목록 1~20
Academic Journal
Nesic, KsenijaKrais, John J.Wang, YifanVandenberg, Cassandra J.Patel, PoojaCai, Kathy Q.Kwan, TanyaLieschke, ElizabethHo, Gwo-YawBarker, Holly E.Bedo, JustinCasadei, SilviaFarrell, AndrewRadke, MarcShield-Artin, KristyPenington, Jocelyn S.Geissler, FranziskaKyran, ElizabethBetsch, RobertXu, LijunZhang, FanDobrovic, AlexanderOlesen, IngerKristeleit, RebeccaOza, AmitMcNeish, IainRatnayake, GayanieTraficante, NadiaChenevix-Trench, G.Green, A.Webb, P.Gertig, D.Fereday, S.Moore, S.Hung, J.Harrap, K.Sadkowsky, T.Pandeya, N.Malt, M.Mellon, A.Robertson, R.Bergh, T. VandenJones, M.Mackenzie, P.Maidens, J.Nattress, K.Chiew, Y. E.Stenlake, A.Sullivan, H.Alexander, B.Ashover, P.Brown, S.Corrish, T.Green, L.Jackman, L.Ferguson, K.Martin, K.Martyn, A.Ranieri, B.White, J.Jayde, V.Mamers, P.Bowes, L.Galletta, L.Giles, D.Hendley, J.Schmidt, T.Shirley, H.Ball, C.Young, C.Viduka, S.Tran, H.Bilic, S.Glavinas, L.Brooks, J.Stuart-Harris, R.Kirsten, F.Rutovitz, J.Clingan, P.Glasgow, A.Proietto, A.Braye, S.Otton, G.Shannon, J.Bonaventura, T.Stewart, J.Begbie, S.Friedlander, M.Bell, D.Baron-Hay, S.Ferrier, A.Gard, G.Nevell, D.Pavlakis, N.Valmadre, S.Young, B.Camaris, C.Crouch, R.Edwards, L.Hacker, N.Marsden, D.Robertson, G.Beale, P.Beith, J.Carter, J.Dalrymple, C.Houghton, R.Russell, P.Links, M.Grygiel, J.Hill, J.Brand, A.Byth, K.Jaworski, R.Harnett, P.Sharma, R.Wain, G.Ward, B.Papadimos, D.Crandon, A.Cummings, M.Horwood, K.Obermair, A.Perrin, L.Wyld, D.Nicklin, J.Davy, M.Oehler, M. K.Hall, C.Dodd, T.Healy, T.Pittman, K.Henderson, D.Miller, J.Pierdes, J.Blomfield, P.Challis, D.McIntosh, R.Parker, A.Brown, B.Rome, R.Allen, D.Grant, P.Hyde, S.Laurie, R.Robbie, M.Healy, D.Jobling, T.Manolitsas, T.McNealage, J.Rogers, P.Susil, B.Sumithran, E.Simpson, I.Phillips, K.Rischin, D.Fox, S.Johnson, D.Lade, S.Loughrey, M.O'Callaghan, N.Murray, W.Waring, P.Billson, V.Pyman, J.Neesham, D.Quinn, M.Underhill, C.Bell, R.Ng, L. F.Blum, R.Ganju, V.Hammond, I.Leung, Y.McCartney, A.Buck, M.Haviv, I.Purdie, D.Whiteman, D.Zeps, N.
Molecular Cancer. August 5, 2024, Vol. 23 Issue 1
Academic Journal
Block, Matthew S., MD, PhD; Vierkant, Robert A., MS; Rambau, Peter F., MD; Winham, Stacey J., PhD; Wagner, Philipp, MD; Traficante, Nadia, BSc; Tołoczko, Aleksandra, MD; Tiezzi, Daniel G., MD, PhD; Taran, Florin Andrei, MD; Sinn, Peter, MD, PhD; Sieh, Weiva, PhD; Sharma, Raghwa, MBBS, FRCPA; Rothstein, Joseph H., MS; Ramón y Cajal, Teresa, MD; Paz-Ares, Luis, MD; Oszurek, Oleg, MD; Orsulic, Sandra, PhD; Ness, Roberta B., MD, MPH; Nelson, Gregg, MD, PhD; Modugno, Francesmary, PhD; Menkiszak, Janusz, MD, PhD; McGuire, Valerie, PhD; McCauley, Bryan M., BS; Mack, Marie, PhD; Lubiński, Jan, MD, PhD; Longacre, Teri A., MD; Li, Zheng, MD; Lester, Jenny, MPH, CCRP; Kennedy, Catherine J., BSc (Hons); Kalli, Kimberly R., PhD; Jung, Audrey Y., PhD; Johnatty, Sharon E., PhD; Jimenez-Linan, Mercedes, MD; Jensen, Allan, PhD; Intermaggio, Maria P., MS; Hung, Jillian, MHS; Herpel, Esther, MD, PhD; Hernandez, Brenda Y., PhD, MPH; Hartkopf, Andreas D., MD; Harnett, Paul R., MBBS, PhD; Ghatage, Prafull, MD; García-Bueno, José M., MD; Gao, Bo, BMed, PhD; Fereday, Sian, BSc, BA; Eilber, Ursula, PhD; Edwards, Robert P., MD; de Sousa, Christiani B., MD, PhD; de Andrade, Jurandyr M., MD, PhD; Chudecka-Głaz, Anita, MD, PhD; Chenevix-Trench, Georgia, PhD; Cazorla, Alicia, MD; Brucker, Sara Y., MD, PhD; Alsop, Jennifer, BA; Whittemore, Alice S., PhD; Steed, Helen, MD; Staebler, Annette, MD; Moysich, Kirsten B., PhD; Menon, Usha, MD; Koziak, Jennifer M., BSc; Kommoss, Stefan, MD; Kjaer, Susanne K., MD; Kelemen, Linda E., ScD; Karlan, Beth Y., MD; Huntsman, David G., MD; Høgdall, Estrid, PhD; Gronwald, Jacek, MD, PhD; Goodman, Marc T., PhD; Gilks, Blake, MD; García, María José, PhD; Fasching, Peter A., MD; de Fazio, Anna, PhD; Deen, Suha, MBChB; Chang-Claude, Jenny, PhD; Candido dos Reis, Francisco J., MD, PhD; Campbell, Ian G., PhD; Brenton, James D., MD, PhD; Bowtell, David D., PhD; Benítez, Javier, PhD; Pharoah, Paul D.P., MD, PhD; Köbel, Martin, MD; Ramus, Susan J., PhD; Goode, Ellen L., PhD, MPH; Bowtell, D.Chenevix-Trench, G.Green, A.Webb, P.DeFazio, A.Gertig, D.Traficante, N.Fereday, S.Moore, S.Hung, J.Harrap, K.Sadkowsky, T.Pandeya, N.Malt, M.Mellon, A.Robertson, R.Vanden Bergh, T.Jones, M.Mackenzie, P.Maidens, J.Nattress, K.Chiew, Y.E.Stenlake, A.Sullivan, H.Alexander, B.Ashover, P.Brown, S.Corrish, T.Green, L.Jackman, L.Ferguson, K.Martin, K.Martyn, A.Ranieri, B.White, J.Jayde, V.Mamers, P.Bowes, L.Galletta, L.Giles, D.Hendley, J.Alsop, K.Schmidt, T.Shirley, H.Ball, C.Young, C.Viduka, S.Tran, HoaBilic, SanelaGlavinas, LydiaBrooks, JuliaStuart-Harris, R.Kirsten, F.Rutovitz, J.Clingan, P.Glasgow, A.Proietto, A.Braye, S.Otton, G.Shannon, J.Bonaventura, T.Stewart, J.Begbie, S.Friedlander, M.Bell, D.Baron-Hay, S.Ferrier, A.Gard, G.Nevell, D.Pavlakis, N.Valmadre, S.Young, B.Camaris, C.Crouch, R.Edwards, L.Hacker, N.Marsden, D.Robertson, G.Beale, P.Beith, J.Carter, J.Dalrymple, C.Houghton, R.Russell, P.Links, M.Grygiel, J.Hill, J.Brand, A.Byth, K.Jaworski, R.Harnett, P.Sharma, R.Wain, G.Ward, B.Papadimos, D.Crandon, A.Cummings, M.Horwood, K.Obermair, A.Perrin, L.Wyld, D.Nicklin, J.Davy, M.Oehler, M.K.Hall, C.Dodd, T.Healy, T.Pittman, K.Henderson, D.Miller, J.Pierdes, J.Blomfield, P.Challis, D.McIntosh, R.Parker, A.Brown, B.Rome, R.Allen, D.Grant, P.Hyde, S.Laurie, R.Robbie, M.Healy, D.Jobling, T.Manolitsas, T.McNealage, J.Rogers, P.Susil, B.Sumithran, E.Simpson, I.Phillips, K.Rischin, D.Fox, S.Johnson, D.Lade, S.Loughrey, M.O'Callaghan, N.Murray, W.Waring, P.Billson, V.Pyman, J.Neesham, D.Quinn, M.Underhill, C.Bell, R.Ng, L.F.Blum, R.Ganju, V.Hammond, I.Leung, Y.McCartney, A.Buck, M.Haviv, I.Purdie, D.Whiteman, D.Zeps, N.
Mayo Clinic Proceedings. 93(3):307-320
Academic Journal
Kang, Eun YoungCheasley, DaneLePage, CecileWakefield, Matthew J.da Cunha Torres, MichelleRowley, SimoneSalazar, CarolinaXing, ZhongyueAllan, PrueBowtell, David D.L.Mes-Masson, Anne-MarieProvencher, Diane M.Rahimi, KuroshKelemen, Linda E.Fasching, Peter A.Doherty, Jennifer A.Goodman, Marc T.Goode, Ellen L.Deen, SuhaPharoah, Paul D.P.Brenton, James D.Sieh, WeivaMateoiu, ConstantinaSundfeldt, KarinCook, Linda S.Le, Nhu D.Anglesio, Michael S.Gilks, C. BlakeHuntsman, David G.Kennedy, Catherine J.Traficante, NadiaBowtell, D.Chenevix-Trench, G.Green, A.Webb, P.DeFazio, A.Gertig, D.Traficante, N.Fereday, S.Moore, S.Hung, J.Harrap, K.Sadkowsky, T.Pandeya, N.Malt, M.Mellon, A.Robertson, R.Bergh, T. VandenJones, M.Mackenzie, P.Maidens, J.Nattress, K.Chiew, Y.E.Stenlake, A.Sullivan, H.Alexander, B.Ashover, P.Brown, S.Corrish, T.Green, L.Jackman, L.Ferguson, K.Martin, K.Martyn, A.Ranieri, B.White, J.Jayde, V.Mamers, P.Bowes, L.Galletta, L.Giles, D.Hendley, J.Alsop, K.Schmidt, T.Shirley, H.Ball, C.Young, C.Viduka, S.Tran, HoaBilic, SanelaGlavinas, LydiaBrooks, JuliaStuart-Harris, R.Kirsten, F.Rutovitz, J.Clingan, P.Glasgow, A.Proietto, A.Braye, S.Otton, G.Shannon, J.Bonaventura, T.Stewart, J.Begbie, S.Friedlander, M.Bell, D.Baron-Hay, S.Ferrier, A.Gard, G.Nevell, D.Pavlakis, N.Valmadre, S.Young, B.Camaris, C.Crouch, R.Edwards, L.Hacker, N.Marsden, D.Robertson, G.Beale, P.Beith, J.Carter, J.Dalrymple, C.Houghton, R.Russell, P.Links, M.Grygiel, J.Hill, J.Brand, A.Byth, K.Jaworski, R.Harnett, P.Sharma, R.Wain, G.Ward, B.Papadimos, D.Crandon, A.Cummings, M.Horwood, K.Obermair, A.Perrin, L.Wyld, D.Nicklin, J.Davy, M.Oehler, M.K.Hall, C.Dodd, T.Healy, T.Pittman, K.Henderson, D.Miller, J.Pierdes, J.Blomfield, P.Challis, D.McIntosh, R.Parker, A.Brown, B.Rome, R.Allen, D.Grant, P.Hyde, S.Laurie, R.Robbie, M.Healy, D.Jobling, T.Manolitsas, T.McNealage, J.Rogers, P.Susil, B.Sumithran, E.Simpson, I.Phillips, K.Rischin, D.Fox, S.Johnson, D.Lade, S.Loughrey, M.O'Callaghan, N.Murray, W.Waring, P.Billson, V.Pyman, J.Neesham, D.Quinn, M.Underhill, C.Bell, R.Ng, L.F.Blum, R.Ganju, V.Hammond, I.Leung, Y.McCartney, A.Buck, M.Haviv, I.Purdie, D.Whiteman, D.Zeps, N.DeFazio, AnnaKaufmann, ScottChurchman, MichaelGourley, CharlieStephens, Andrew N.Meagher, Nicola S.Ramus, Susan J.Antill, Yoland C.Campbell, IanScott, Clare L.Köbel, MartinGorringe, Kylie L.Ryland, Georgina L.Allan, Prue E.Alsop, KathrynAnanda, SumitraAu-Yeung, GeorgeBöhm, MaretBrand, AlisonChenevix-Trench, GeorgiaChristie, MichaelChiew, Yoke-EngDudley, RhiannonFairweather, NicoleFereday, SianFox, Stephen B.Hacker, Neville F.Hadley, Alison M.Hendley, JoyHo, Gwo-YawHunter, Sally M.Jobling, Tom W.Kalli, Kimberly R.Kaufmann, Scott H.Le Page, CecileMcNally, Orla M.McAlpine, Jessica N.Mileshkin, LindaPyman, JanSamimi, GoliSharma, RagwhaCampbell, Ian G.
In Modern Pathology January 2021 34(1):194-206
Academic Journal
Bowtell, D.Chenevix-Trench, G.Green, A.Webb, P.DeFazio, A.Gertig, D.Traficante, N.Fereday, S.Moore, S.Hung, J.Harrap, K.Sadkowsky, T.Pandeya, N.Malt, M.Mellon, A.Robertson, R.Vanden Bergh, T.Jones, M.Mackenzie, P.Maidens, J.Nattress, K.Chiew, Y.E.Stenlake, A.Sullivan, H.Alexander, B.Ashover, P.Brown, S.Corrish, T.Green, L.Jackman, L.Ferguson, K.Martin, K.Martyn, A.Ranieri, B.White, J.Jayde, V.Mamers, P.Bowes, L.Galletta, L.Giles, D.Hendley, J.Alsop, K.Schmidt, T.Shirley, H.Ball, C.Young, C.Viduka, S.Tran, HoaBilic, SanelaGlavinas, LydiaBrooks, JuliaStuart-Harris, R.Kirsten, F.Rutovitz, J.Clingan, P.Glasgow, A.Proietto, A.Braye, S.Otton, G.Shannon, J.Bonaventura, T.Stewart, J.Begbie, S.Friedlander, M.Bell, D.Baron-Hay, S.Ferrier,a, A.Gard, G.Nevell, D.Pavlakis, N.Valmadre, S.Young, B.Camaris, C.Crouch, R.Edwards, L.Hacker, N.Marsden, D.Robertson, G.Beale, P.Beith, J.Carter, J.Dalrymple, C.Houghton, R.Russell, P.Links, M.Grygiel, J.Hill, J.Brand, A.Byth, K.Jaworski, R.Harnett, P.Sharma, R.Wain, G.Ward, B.Papadimos, D.Crandon, A.Cummings, M.Horwood, K.Obermair, A.Perrin, L.Wyld, D.Nicklin, J.Davy, M.Oehler, M.K.Hall, C.Dodd, T.Healy, T.Pittman, K.Henderson, D.Miller, J.Pierdes, J.Blomfield, P.Challis, D.McIntosh, R.Parker, A.Brown, B.Rome, R.Allen, D.Grant, P.Hyde, S.Laurie, R.Robbie, M.Healy, D.Jobling, T.Manolitsas, T.McNealage, J.Rogers, P.Susil, B.Sumithran, E.Simpson, I.Phillips, K.Rischin, D.Fox, S.Johnson, D.Lade, S.Loughrey, M.O’Callaghan, N.Murray, W.Waring, P.Billson, V.Pyman, J.Neesham, D.Quinn, M.Underhill, C.Bell, R.Ng, L.F.Blum, R.Ganju, V.Hammond, I.Leung, Y.McCartney, A.Buck, M.Haviv, I.Purdie, D.Whiteman, D.Zeps, N.Millstein, J.Budden, T.Goode, E.L.Anglesio, M.S.Talhouk, A.Intermaggio, M.P.Leong, H.S.Chen, S.Elatre, W.Gilks, B.Nazeran, T.Volchek, M.Bentley, R.C.Wang, C.Chiu, D.S.Kommoss, S.Leung, S.C.Y.Senz, J.Lum, A.Chow, V.Sudderuddin, H.Mackenzie, R.George, J.Steed, H.Koziak, J.M.Köbel, M.McNeish, I.A.Goranova, T.Ennis, D.Macintyre, G.Silva De Silva, D.Ramón y Cajal, T.García-Donas, J.Hernando Polo, S.Rodriguez, G.C.Cushing-Haugen, K.L.Harris, H.R.Greene, C.S.Zelaya, R.A.Behrens, S.Fortner, R.T.Sinn, P.Herpel, E.Lester, J.Lubiński, J.Oszurek, O.Tołoczko, A.Cybulski, C.Menkiszak, J.Pearce, C.L.Pike, M.C.Tseng, C.Alsop, J.Rhenius, V.Song, H.Jimenez-Linan, M.Piskorz, A.M.Gentry-Maharaj, A.Karpinskyj, C.Widschwendter, M.Singh, N.Kennedy, C.J.Harnett, P.R.Gao, B.Johnatty, S.E.Sayer, R.Boros, J.Winham, S.J.Keeney, G.L.Kaufmann, S.H.Larson, M.C.Luk, H.Hernandez, B.Y.Thompson, P.J.Wilkens, L.R.Carney, M.E.Trabert, B.Lissowska, J.Brinton, L.Sherman, M.E.Bodelon, C.Hinsley, S.Lewsley, L.A.Glasspool, R.Banerjee, S.N.Stronach, E.A.Haluska, P.Ray-Coquard, I.Mahner, S.Winterhoff, B.Slamon, D.Levine, D.A.Kelemen, L.E.Benitez, J.Chang-Claude, J.Gronwald, J.Wu, A.H.Menon, U.Goodman, M.T.Schildkraut, J.M.Wentzensen, N.Brown, R.Berchuck, A.deFazio, A.Gayther, S.A.García, M.J.Henderson, M.J.Rossing, M.A.Beeghly-Fadiel, A.Fasching, P.A.Orsulic, S.Karlan, B.Y.Konecny, G.E.Huntsman, D.G.Bowtell, D.D.Brenton, J.D.Doherty, J.A.Pharoah, P.D.P.Ramus, S.J.
In Annals of Oncology September 2020 31(9):1240-1250
Academic Journal
Olsen, Catherine M.Nagle, Christina M.Bowtell, D.Chenevix-Trench, G.Green, A.DeFazio, A.Gertig, D.Traficante, N.Moore, S.Hung, J.Fereday, S.Harrap, K.Sadkowsky, T.Mellon, A.Robertson, R.Vanden Bergh, T.Maidens, J.Nattress, K.Chiew, Y. E.Stenlake, A.Sullivan, H.Alexander, B.Ashover, P.Brown, S.Corrish, T.Green, L.Jackman, L.Martin, K.Ranieri, B.White, J.Jayde, V.Bowes, L.Mamers, P.Schmidt, T.Shirley, H.Viduka, S.Tran, HoaBilic, SanelaGlavinas, LydiaProietto, A.Braye, S.Otton, G.Bonaventura, T.Stewart, J.Friedlander, M.Bell, D.Baron-Hay, S.Ferrier, A.Gard, G.Nevell, D.Young, B.Camaris, C.Crouch, R.Edwards, L.Hacker, N.Marsden, D.Robertson, G.Beale, P.Beith, J.Carter, J.Dalrymple, C.Hamilton, A.Houghton, R.Russell, P.Brand, A.Jaworski, R.Harnett, P.Wain, G.Crandon, A.Cummings, M.Horwood, K.Obermair, A.Wyld, D.Nicklin, J.Perrin, L.Ward, B.Davy, M.Hall, C.Dodd, T.Healy, T.Pittman, K.Henderson, D.Miller, J.Pierdes, J.Blomfield, P.Challis, D.McIntosh, R.Parker, A.Brown, B.Rome, R.Allen, D.Grant, P.Hyde, S.Laurie, R.Robbie, M.Healy, D.Jobling, T.Maniolitas, T.McNealage, J.Rogers, P.Susil, B.Veitch, A.Constable, J.Ping Tong, S.Robinson, I.Simpson, I.Phillips, K.Rischin, D.Waring, P.Loughrey, M.O'Callaghan, N.Murray, BillBillson, V.Galloway, S.Pyman, J.Quinn, M.Hammond, I.McCartney, A.Leung, Y.Haviv, I.Zeps, N.Green, A. C.Parsons, P. G.Hayward, N.Webb, P.Purdie, D.Whiteman, D.
Olsen, C M, Nagle, C M, Bowtell, D, Chenevix-Trench, G, Green, A, DeFazio, A, Gertig, D, Traficante, N, Moore, S, Hung, J, Fereday, S, Harrap, K, Sadkowsky, T, Mellon, A, Robertson, R, Vanden Bergh, T, Maidens, J, Nattress, K, Chiew, Y E, Stenlake, A, Sullivan, H, Alexander, B, Ashover, P, Brown, S, Corrish, T, Green, L, Jackman, L, Martin, K, Ranieri, B, White, J, Jayde, V, Bowes, L, Mamers, P, Schmidt, T, Shirley, H, Viduka, S, Tran, H, Bilic, S, Glavinas, L, Proietto, A, Braye, S, Otton, G, Bonaventura, T, Stewart, J, Friedlander, M, Bell, D, Baron-Hay, S, Ferrier, A, Gard, G, Nevell, D, Young, B, Camaris, C, Crouch, R, Edwards, L, Hacker, N, Marsden, D, Robertson, G, Beale, P, Beith, J, Carter, J, Dalrymple, C, Hamilton, A, Houghton, R, Russell, P, Brand, A, Jaworski, R, Harnett, P, Wain, G, Crandon, A, Cummings, M, Horwood, K, Obermair, A, Wyld, D, Nicklin, J, Perrin, L, Ward, B, Davy, M, Hall, C, Dodd, T, Healy, T, Pittman, K, Henderson, D, Miller, J, Pierdes, J, Blomfield, P, Challis, D, McIntosh, R, Parker, A, Brown, B, Rome, R, Allen, D, Grant, P, Hyde, S, Laurie, R, Robbie, M, Healy, D, Jobling, T, Maniolitas, T, McNealage, J, Rogers, P, Susil, B, Veitch, A, Constable, J, Ping Tong, S, Robinson, I, Simpson, I, Phillips, K, Rischin, D, Waring, P, Loughrey, M, O'Callaghan, N, Murray, B, Billson, V, Galloway, S, Pyman, J, Quinn, M, Hammond, I, McCartney, A, Leung, Y, Haviv, I, Zeps, N, Green, A C, Parsons, P G, Hayward, N, Webb, P, Purdie, D & Whiteman, D 2008, 'Body size and risk of epithelial ovarian and related cancers: A population-based case-control study', International Journal of Cancer, vol. 123, no. 2, pp. 450-456. https://doi.org/10.1002/ijc.23509
Academic Journal
Olsen, Catherine M.Bain, Christopher J.Jordan, Susan J.Nagle, Christina M.Bowtell, D.Chenevix-Trench, G.Green, A.Webb, P.Defazio, A.Gertig, D.Traficante, N.Moore, S.Hung, J.Fereday, S.Harrap, K.Sadkowsky, T.Mellon, A.Robertson, R.Vanden Bergh, T.Maidens, J.Nattress, K.Chiew, Y. E.Stenlake, A.Sullivan, H.Alexander, B.Ashover, P.Brown, S.Corrish, T.Green, L.Jackman, L.Martin, K.Ranieri, B.White, J.Jayde, V.Bowes, L.Mamers, P.Schmidt, T.Shirley, H.Viduka, S.Tran, H.Bilic, S.Glavinas, L.Proietto, A.Braye, S.Otton, G.Bonaventura, T.Stewart, J.Friedlander, M.Bell, D.Baron-Hay, S.Ferrier, A.Gard, G.Nevell, D.Young, B.Camaris, C.Crouch, R.Edwards, L.Hacker, N.Marsden, D.Robertson, G.Beale, P.Beith, J.Carter, J.Dalrymple, C.Hamilton, A.Houghton, R.Russell, P.Brand, A.Jaworski, R.Harnett, P.Wain, G.Crandon, A.Cummings, M.Horwood, K.Obermair, A.Wyld, D.Nicklin, J.Perrin, L.Ward, B.Davy, M.Hall, C.Dodd, T.Healy, T.Pittman, K.Henderson, D.Hyde, S.Miller, J.Pierdes, J.Blomfield, P.Challis, D.McIntosh, R.Parker, A.Brown, B.Rome, R.Allen, D.Grant, P.Laurie, R.Robbie, M.Healy, D.Jobling, T.Maniolitas, T.McNealage, J.Rogers, P.Susil, B.Veitch, A.Constable, J.Ping Tong, S.Robinson, I.Simpson, I.Phillips, K.Rischin, D.Waring, P.Loughrey, M.O'Callaghan, N.Murray, BillBillson, V.Galloway, S.Pyman, J.Quinn, M.Hammond, I.McCartney, A.Leung, Y.Haviv, I.Purdie, D.Whiteman, D.Zeps, N.Green, A. C.Parsons, P. G.Hayward, N.
Olsen, C M, Bain, C J, Jordan, S J, Nagle, C M, Bowtell, D, Chenevix-Trench, G, Green, A, Webb, P, Defazio, A, Gertig, D, Traficante, N, Moore, S, Hung, J, Fereday, S, Harrap, K, Sadkowsky, T, Mellon, A, Robertson, R, Vanden Bergh, T, Maidens, J, Nattress, K, Chiew, Y E, Stenlake, A, Sullivan, H, Alexander, B, Ashover, P, Brown, S, Corrish, T, Green, L, Jackman, L, Martin, K, Ranieri, B, White, J, Jayde, V, Bowes, L, Mamers, P, Schmidt, T, Shirley, H, Viduka, S, Tran, H, Bilic, S, Glavinas, L, Proietto, A, Braye, S, Otton, G, Bonaventura, T, Stewart, J, Friedlander, M, Bell, D, Baron-Hay, S, Ferrier, A, Gard, G, Nevell, D, Young, B, Camaris, C, Crouch, R, Edwards, L, Hacker, N, Marsden, D, Robertson, G, Beale, P, Beith, J, Carter, J, Dalrymple, C, Hamilton, A, Houghton, R, Russell, P, Brand, A, Jaworski, R, Harnett, P, Wain, G, Crandon, A, Cummings, M, Horwood, K, Obermair, A, Wyld, D, Nicklin, J, Perrin, L, Ward, B, Davy, M, Hall, C, Dodd, T, Healy, T, Pittman, K, Henderson, D, Hyde, S, Miller, J, Pierdes, J, Blomfield, P, Challis, D, McIntosh, R, Parker, A, Brown, B, Rome, R, Allen, D, Grant, P, Laurie, R, Robbie, M, Healy, D, Jobling, T, Maniolitas, T, McNealage, J, Rogers, P, Susil, B, Veitch, A, Constable, J, Ping Tong, S, Robinson, I, Simpson, I, Phillips, K, Rischin, D, Waring, P, Loughrey, M, O'Callaghan, N, Murray, B, Billson, V, Galloway, S, Pyman, J, Quinn, M, Hammond, I, McCartney, A, Leung, Y, Haviv, I, Purdie, D, Whiteman, D, Zeps, N, Green, A C, Parsons, P G & Hayward, N 2007, 'Recreational physical activity and epithelial ovarian cancer: A case-control study, systematic review, and meta-analysis', Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 11, pp. 2321-2330. https://doi.org/10.1158/1055-9965.EPI-07-0566
Academic Journal
Merritt, Melissa A.Nagle, Christina M.Bowtell, D.Chenevix-Trench, G.Green, A.DeFazio, A.Gertig, D.Traficante, N.Moore, S.Hung, J.Fereday, S.Harrap, K.Sadkowsky, T.Mellon, A.Robertson, R.Vanden Bergh, T.Maidens, J.Nattress, K.Chiew, Y. E.Stenlake, A.Sullivan, H.Alexander, B.Ashover, P.Brown, S.Corrish, T.Green, L.Jackman, L.Martin, K.Ranieri, B.White, J.Jayde, V.Bowes, L.Mamers, P.Schmidt, T.Shirley, H.Viduka, S.Tran, HoaBilic, SanelaGlavinas, LydiaProietto, A.Braye, S.Otton, G.Bonaventura, T.Stewart, J.Friedlander, M.Bell, D.Baron-Hay, S.Ferrier, A.Gard, G.Nevell, D.Young, B.Camaris, C.Crouch, R.Edwards, L.Hacker, N.Marsden, D.Robertson, G.Beale, P.Beith, J.Carter, J.Dalrymple, C.Hamilton, A.Houghton, R.Russell, P.Brand, A.Jaworski, R.Harnett, P.Wain, G.Crandon, A.Cummings, M.Horwood, K.Obermair, A.Wyld, D.Nicklin, J.Perrin, L.Ward, B.Davy, M.Hall, C.Dodd, T.Healy, T.Pittman, K.Henderson, D.Miller, J.Pierdes, J.Blomfield, P.Challis, D.McIntosh, R.Parker, A.Brown, B.Rome, R.Allen, D.Grant, P.Hyde, S.Laurie, R.Robbie, M.Healy, D.Jobling, T.Maniolitas, T.McNealage, J.Rogers, P.Susil, B.Veitch, A.Constable, J.Ping Tong, S.Robinson, I.Simpson, I.Phillips, K.Rischin, D.Waring, P.Loughrey, M.O'Callaghan, N.Murray, BillBillson, V.Galloway, S.Pyman, J.Quinn, M.Hammond, I.McCartney, A.Leung, Y.Haviv, I.Zeps, N.Green, A. C.Parsons, P. G.Hayward, N.Webb, P.Purdie, D.Whiteman, D.
Merritt, M A, Nagle, C M, Bowtell, D, Chenevix-Trench, G, Green, A, DeFazio, A, Gertig, D, Traficante, N, Moore, S, Hung, J, Fereday, S, Harrap, K, Sadkowsky, T, Mellon, A, Robertson, R, Vanden Bergh, T, Maidens, J, Nattress, K, Chiew, Y E, Stenlake, A, Sullivan, H, Alexander, B, Ashover, P, Brown, S, Corrish, T, Green, L, Jackman, L, Martin, K, Ranieri, B, White, J, Jayde, V, Bowes, L, Mamers, P, Schmidt, T, Shirley, H, Viduka, S, Tran, H, Bilic, S, Glavinas, L, Proietto, A, Braye, S, Otton, G, Bonaventura, T, Stewart, J, Friedlander, M, Bell, D, Baron-Hay, S, Ferrier, A, Gard, G, Nevell, D, Young, B, Camaris, C, Crouch, R, Edwards, L, Hacker, N, Marsden, D, Robertson, G, Beale, P, Beith, J, Carter, J, Dalrymple, C, Hamilton, A, Houghton, R, Russell, P, Brand, A, Jaworski, R, Harnett, P, Wain, G, Crandon, A, Cummings, M, Horwood, K, Obermair, A, Wyld, D, Nicklin, J, Perrin, L, Ward, B, Davy, M, Hall, C, Dodd, T, Healy, T, Pittman, K, Henderson, D, Miller, J, Pierdes, J, Blomfield, P, Challis, D, McIntosh, R, Parker, A, Brown, B, Rome, R, Allen, D, Grant, P, Hyde, S, Laurie, R, Robbie, M, Healy, D, Jobling, T, Maniolitas, T, McNealage, J, Rogers, P, Susil, B, Veitch, A, Constable, J, Ping Tong, S, Robinson, I, Simpson, I, Phillips, K, Rischin, D, Waring, P, Loughrey, M, O'Callaghan, N, Murray, B, Billson, V, Galloway, S, Pyman, J, Quinn, M, Hammond, I, McCartney, A, Leung, Y, Haviv, I, Zeps, N, Green, A C, Parsons, P G, Hayward, N, Webb, P, Purdie, D & Whiteman, D 2008, 'Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer', International Journal of Cancer, vol. 122, no. 1, pp. 170-176. https://doi.org/10.1002/ijc.23017
Academic Journal
Nikki L. BurdettMadelynne O. WillisAhwan PandeyLaura TwomeySara AlaeiD. BowtellG. Chenevix-TrenchA. GreenP. WebbA. DeFazioD. GertigN. TraficanteS. FeredayS. MooreJ. HungK. HarrapT. SadkowskyN. PandeyaL. BowesL. GallettaD. GilesJ. HendleyK. AlsopB. AlexanderP. AshoverS. BrownT. CorrishL. GreenL. JackmanK. FergusonK. MartinA. MartynB. RanieriM. MaltY. E. ChiewA. StenlakeH. SullivanA. MellonR. RobertsonT. Vanden BerghM. JonesP. MackenzieJ. MaidensK. NattressJ. WhiteV. JaydeP. MamersT. SchmidtH. ShirleyS. VidukaH. TranS. BilicL. GlavinasC. BallC. YoungJ. BrooksL. MileshkinG. Au-YeungK. PhillipsD. RischinN. BurdettR. DelahuntyE. ChristieD. GarsedS. FoxD. JohnsonS. LadeM. LoughreyN. O’CallaghanW. MurrayD. PurdieD. WhitemanA. ProiettoS. BrayeG. OttonC. CamarisR. CrouchL. EdwardsN. HackerD. MarsdenG. RobertsonD. BellS. Baron-HayA. FerrierG. GardD. NevellN. PavlakisS. ValmadreB. YoungP. BealeJ. BeithJ. CarterC. DalrympleR. HoughtonP. RussellM. DavyM. K. OehlerC. HallT. DoddP. BlomfieldD. ChallisR. McIntoshA. ParkerD. HealyT. JoblingT. ManolitsasJ. McNealageP. RogersB. SusilE. SumithranI. SimpsonN. ZepsI. HammondY. LeungA. McCartneyR. Stuart-HarrisF. KirstenJ. RutovitzP. ClinganJ. ShannonT. BonaventuraJ. StewartS. BegbieA. GlasgowM. FriedlanderM. LinksJ. GrygielJ. HillA. BrandK. BythP. HarnettG. WainR. JaworskiR. SharmaB. WardD. PapadimosA. CrandonM. CummingsK. HorwoodA. ObermairL. PerrinD. WyldJ. NicklinT. HealyK. PittmanD. HendersonJ. MillerJ. PierdesB. BrownR. RomeD. AllenP. GrantS. HydeR. LaurieM. RobbieP. WaringV. BillsonJ. PymanD. NeeshamM. QuinnC. UnderhillR. BellL. F. NgR. BlumV. GanjuM. BuckI. HavivDavid D. L. BowtellElizabeth L. Christie
Nat Commun
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Academic Journal
Amber A DeVriesJoe DennisJonathan P TyrerPei-Chen PengSimon G CoetzeeAlberto L ReyesJasmine T PlummerBrian D DavisStephanie S ChenFelipe Segato DezemKatja K H AbenHoda Anton-CulverNatalia N AntonenkovaMatthias W BeckmannAlicia Beeghly-FadielAndrew BerchuckNatalia V BogdanovaNadja Bogdanova-MarkovJames D BrentonRalf ButzowIan CampbellJenny Chang-ClaudeGeorgia Chenevix-TrenchLinda S CookAnna DeFazioJennifer A DohertyThilo DörkDiana M EcclesA Heather EliassenPeter A FaschingRenée T FortnerGraham G GilesEllen L GoodeMarc T GoodmanJacek GronwaldP WebbA DeFazioM FriedlanderA ObermairP GrantC NagleV BeesleyG Chevenix-TrenchD BowtellP BlomfieldA BrandA DavisY LeungJ NicklinM QuinnK LivingstoneH O'NeillM WilliamsA BlackA HadleyA GlasgowA GarrettA RaoC ShannonC SteerD AllenD NeeshamG OttonG Au-YeungG GossG WainG GardG RobertsonJ LombardJ TanJ McNeilageJ PowerJ CowardJ MillerJ CarterJ LamontK M WongK ReidL PerrinL MilishkinM NascimentoM BuckM BuntingM HarrisonN ChettyN HackerO McNallyP HarnettP BealeR AwadR MohanR FarrellR McIntoshR RomeR SayerR HoughtonR HoggR LandS Baron-HayS ParamasivumS PatherS HydeS SalfingerS ValmadreT JoblingT ManolitsasT BonaventuraV AroraG Chenevix-TrenchA GreenD GertigN TraficanteS FeredayS MooreJ HungK HarrapT SadkowskyN PandeyaM MaltR RobertsonT Vanden BerghM JonesP McKenzieJ MaidensK NattressY E ChiewA StenlakeH SullivanB AlexanderP AshoverS BrownT CorrishL GreenL JackmanK FergusonK MartinA MartynB RanieriJ WhiteV JaydeL BowesP MamersL GallettaD GilesJ HendleyK AlsopT SchmidtH ShirleyC BallC YoungS VidukaH TranS BilicL GlavinasJ BrooksR Stuart-HarrisF KirstenJ RutovitzP ClinganA ProiettoS BrayeJ ShannonJ StewartS BegbieNiclas HåkanssonMichelle A T HildebrandtChad HuffDavid G HuntsmanAllan JensenSiddhartha KarBeth Y KarlanElza K KhusnutdinovaLambertus A KiemeneySusanne K KjaerJolanta KupryjanczykMarilyne LabrieDiether LambrechtsNhu D LeJan LubińskiTaymaa MayUsha MenonRoger L MilneFrancesmary ModugnoAlvaro N MonteiroKirsten B MoysichKunle OdunsiHåkan OlssonCeleste L PearceTanja PejovicSusan J RamusElio RiboliMarjorie J RigganIsabelle RomieuDale P SandlerJoellen M SchildkrautV Wendy SetiawanWeiva SiehHonglin SongRebecca SutphenKathryn L TerryPamela J ThompsonLinda TitusShelley S TworogerEls Van NieuwenhuysenDigna Velez EdwardsPenelope M WebbNicolas WentzensenAlice S WhittemoreAlicja WolkAnna H WuArgyrios ZiogasMatthew L FreedmanKate LawrensonPaul D P PharoahDouglas F EastonSimon A GaytherMichelle R Jones
J Natl Cancer Inst
Journal of the National Cancer Institute, 114, 11, pp. 1533-1544
Devries, A A, Dennis, J, Tyrer, J P, Peng, P, Coetzee, S G, Reyes, A L, Plummer, J T, Davis, B D, Chen, S S, Dezem, F S, Aben, K K H, Anton-culver, H, Antonenkova, N N, Beckmann, M W, Beeghly-fadiel, A, Berchuck, A, Bogdanova, N V, Bogdanova-markov, N, Brenton, J D, Butzow, R, Campbell, I, Chang-claude, J, Chenevix-trench, G, Cook, L S, Defazio, A, Doherty, J A, Dörk, T, Eccles, D M, Eliassen, A H, Fasching, P A, Fortner, R T, Giles, G G, Goode, E L, Goodman, M T, Gronwald, J, Webb, P, Defazio, A, Friedlander, M, Obermair, A, Grant, P, Nagle, C, Beesley, V, Chevenix-trench, G, Bowtell, D, Blomfield, P, Brand, A, Davis, A, Leung, Y, Nicklin, J, Quinn, M, Livingstone, K, O'neill, H, Williams, M, Black, A, Hadley, A, Glasgow, A, Garrett, A, Rao, A, Shannon, C, Steer, C, Allen, D, Neesham, D, Otton, G, Au-yeung, G, Goss, G, Wain, G, Gard, G, Robertson, G, Lombard, J, Tan, J, Mcneilage, J, Power, J, Coward, J, Miller, J, Carter, J, Lamont, J, Wong, K M, Reid, K, Perrin, L, Milishkin, L, Nascimento, M, Buck, M, Bunting, M, Harrison, M, Chetty, N, Hacker, N, Mcnally, O, Harnett, P, Beale, P, Awad, R, Mohan, R, Farrell, R, Mcintosh, R, Rome, R, Sayer, R, Houghton, R, Hogg, R, Land, R, Baron-hay, S, Paramasivum, S, Pather, S, Hyde, S, Salfinger, S, Valmadre, S, Jobling, T, Manolitsas, T, Bonaventura, T, Arora, V, Bowtell, D, Chenevix-trench, G, Green, A, Webb, P, Defazio, A, Gertig, D, Traficante, N, Fereday, S, Moore, S, Hung, J, Harrap, K, Sadkowsky, T, Pandeya, N, Malt, M, Robertson, R, Bergh, T V, Jones, M, Mckenzie, P, Maidens, J, Nattress, K, Chiew, Y E, Stenlake, A, Sullivan, H, Alexander, B, Ashover, P, Brown, S, Corrish, T, Green, L, Jackman, L, Ferguson, K, Martin, K, Martyn, A, Ranieri, B, White, J, Jayde, V, Bowes, L, Mamers, P, Galletta, L, Giles, D, Hendley, J, Alsop, K, Schmidt, T, Shirley, H, Ball, C, Young, C, Viduka, S, Tran, H, Bilic, S, Glavinas, L, Brooks, J, Stuart-harris, R, Kirsten, F, Rutovitz, J, Clingan, P, Glasgow, A, Proietto, A, Braye, S, Otton, G, Shannon, J, Bonaventura, T, Stewart, J, Begbie, S, Håkansson, N, Hildebrandt, M A T, Huff, C, Huntsman, D G, Jensen, A, Kar, S, Karlan, B Y, Khusnutdinova, E K, Kiemeney, L A, Kjaer, S K, Kupryjanczyk, J, Labrie, M, Lambrechts, D, Le, N D, Lubiński, J, May, T, Menon, U, Milne, R L, Modugno, F, Monteiro, A N, Moysich, K B, Odunsi, K, Olsson, H, Pearce, C L, Pejovic, T, Ramus, S J, Riboli, E, Riggan, M J, Romieu, I, Sandler, D P, Schildkraut, J M, Setiawan, V W, Sieh, W, Song, H, Sutphen, R, Terry, K L, Thompson, P J, Titus, L, Tworoger, S S, Van Nieuwenhuysen, E, Edwards, D V, Webb, P M, Wentzensen, N, Whittemore, A S, Wolk, A, Wu, A H, Ziogas, A, Freedman, M L, Lawrenson, K, Pharoah, P D P, Easton, D F, Gayther, S A & Jones, M R 2022, 'Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci', Journal of the National Cancer Institute, vol. 114, no. 11, djac160, pp. 1533–1544. https://doi.org/10.1093/jnci/djac160
DeVries, A A, Dennis, J, Tyrer, J P, Peng, P-C, Coetzee, S G, Reyes, A L, Plummer, J T, Davis, B D, Chen, S S, Dezem, F S, Aben, K K H, Anton-Culver, H, Antonenkova, N N, Beckmann, M W, Beeghly-Fadiel, A, Berchuck, A, Bogdanova, N, Bogdanova-Markov, N, Brenton, J D, Butzow, R, Campbell, I, Chang-Claude, J, Chenevix-Trench, G, Cook, L S, DeFazio, A, Doherty, J A, Dork, T, Eccles, D M, Eliassen, A H, Fasching, P A, Fortner, R T, Giles, G G, Goode, E L, Goodman, M T, Gronwald, J, Hakansson, N, Hildebrandt, M A T, Huff, C, Huntsman, D G, Jensen, A, Kar, S, Karlan, B Y, Khusnutdinova, E K, Kiemeney, L A, Kjaer, S K, Kupryjanczyk, J, Labrie, M, Lambrechts, D, Le, N D, Lubinski, J, OPAL Study Grp & AOCS Grp 2022, ' Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci ', Journal of the National Cancer Institute, vol. 114, no. 11, pp. 1533–1544 . https://doi.org/10.1093/jnci/djac160
Journal of the National Cancer Institute, vol 114, iss 11
Academic Journal
Nikki L. BurdettMadelynne O. WillisAhwan PandeySian FeredayD. BowtellG. Chenevix-TrenchA. GreenP. WebbA. DeFazioD. GertigN. TraficanteS. FeredayS. MooreJ. HungK. HarrapT. SadkowskyN. PandeyaM. MaltA. MellonR. RobertsonT. Vanden BerghM. JonesP. MackenzieJ. MaidensK. NattressY. E. ChiewA. StenlakeH. SullivanB. AlexanderP. AshoverS. BrownT. CorrishL. GreenL. JackmanK. FergusonK. MartinA. MartynB. RanieriJ. WhiteV. JaydeP. MamersL. BowesL. GallettaD. GilesJ. HendleyK. AlsopT. SchmidtH. ShirleyC. BallC. YoungS. VidukaHoa TranSanela BilicLydia GlavinasJulia BrooksR. Stuart-HarrisF. KirstenJ. RutovitzP. ClinganA. GlasgowA. ProiettoS. BrayeG. OttonJ. ShannonT. BonaventuraJ. StewartS. BegbieM. FriedlanderD. BellS. Baron-HayA. FerrierG. GardD. NevellN. PavlakisS. ValmadreB. YoungC. CamarisR. CrouchL. EdwardsN. HackerD. MarsdenG. RobertsonP. BealeJ. BeithJ. CarterC. DalrympleR. HoughtonP. RussellM. LinksJ. GrygielJ. HillA. BrandK. BythR. JaworskiP. HarnettR. SharmaG. WainB. WardD. PapadimosA. CrandonM. CummingsK. HorwoodA. ObermairL. PerrinD. WyldJ. NicklinM. DavyM. K. OehlerC. HallT. DoddT. HealyK. PittmanD. HendersonJ. MillerJ. PierdesP. BlomfieldD. ChallisR. McIntoshA. ParkerB. BrownR. RomeD. AllenP. GrantS. HydeR. LaurieM. RobbieD. HealyT. JoblingT. ManolitsasJ. McNealageP. RogersB. SusilE. SumithranI. SimpsonL. MileshkinG. Au-YeungK. PhillipsD. RischinS. FoxD. JohnsonS. LadeM. LoughreyN. O’CallaghanW. MurrayP. WaringV. BillsonJ. PymanD. NeeshamM. QuinnC. UnderhillR. BellL. F. NgR. BlumV. GanjuI. HammondY. LeungA. McCartneyM. BuckI. HavivD. PurdieD. WhitemanN. ZepsAnna DeFazioDavid D. L. BowtellElizabeth L. Christie
Sci Rep
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Academic Journal
Olga KondrashovaMonique ToppKsenija NesicElizabeth LieschkeGwo-Yaw HoMaria I. HarrellGiada V. ZapparoliAlison HadleyRobert HolianEmma BoehmValerie HeongElaine SanijRichard B. PearsonJohn J. KraisNeil JohnsonOrla McNallySumitra AnandaKathryn AlsopKarla J. HuttScott H. KaufmannKevin K. LinThomas C. HardingNadia TraficanteG. Chenevix-TrenchA. GreenP. WebbD. GertigS. FeredayS. MooreJ. HungK. HarrapT. SadkowskyN. PandeyaM. MaltA. MellonR. RobertsonT. Vanden BerghM. JonesP. MackenzieJ. MaidensK. NattressY. E. ChiewA. StenlakeH. SullivanB. AlexanderP. AshoverS. BrownT. CorrishL. GreenL. JackmanK. FergusonK. MartinA. MartynB. RanieriJ. WhiteV. JaydeP. MamersL. BowesL. GallettaD. GilesJ. HendleyT. SchmidtH. ShirleyC. BallC. YoungS. VidukaH. TranS. BilicL. GlavinasJ. BrooksR. Stuart-HarrisF. KirstenJ. RutovitzP. ClinganA. GlasgowA. ProiettoS. BrayeG. OttonJ. ShannonT. BonaventuraJ. StewartS. BegbieM. FriedlanderD. BellS. Baron-HayA. FerrierG. GardD. NevellN. PavlakisS. ValmadreB. YoungC. CamarisR. CrouchL. EdwardsN. HackerD. MarsdenG. RobertsonP. BealeJ. BeithJ. CarterC. DalrympleR. HoughtonP. RussellM. LinksJ. GrygielJ. HillA. BrandK. BythR. JaworskiP. HarnettR. SharmaG. WainB. WardD. PapadimosA. CrandonM. CummingsK. HorwoodA. ObermairL. PerrinD. WyldJ. NicklinM. DavyM. K. OehlerC. HallT. DoddT. HealyK. PittmanD. HendersonJ. MillerJ. PierdesP. BlomfieldD. ChallisR. McIntoshA. ParkerB. BrownR. RomeD. AllenP. GrantS. HydeR. LaurieM. RobbieD. HealyT. JoblingT. ManolitsasJ. McNealageP. RogersB. SusilE. SumithranI. SimpsonK. PhillipsD. RischinS. FoxD. JohnsonS. LadeM. LoughreyN. O’CallaghanW. MurrayP. WaringV. BillsonJ. PymanD. NeeshamM. QuinnC. UnderhillR. BellL. F. NgR. BlumV. GanjuI. HammondY. LeungA. McCartneyM. BuckI. HavivD. PurdieD. WhitemanN. ZepsAnna deFazioIain A. McNeishDavid D. BowtellElizabeth M. SwisherAlexander DobrovicMatthew J. WakefieldClare L. Scott
Nat Commun
Nature Communications, Vol 9, Iss 1, Pp 1-16 (2018)
Academic Journal
Moujaber, TaniaEtemadmoghadam, DariushKennedy, Catherine J.Chiew, Yoke-EngBalleine, Rosemary L.Saunders, CatherineWain, Gerard, VGao, BoHogg, RussellSrirangan, SivatharsnyKan, CasinaFereday, SianTraficante, NadiaPatch, Ann-MariePearson, John, VWaddell, NicolaGrimmond, Sean M.Dobrovic, AlexanderBowtell, David D. L.Harnett, Paul R.DeFazio, AnnaBowtell, D.Chenevix-Trench, G.Green, A.Webb, P.DeFazio, A.Gertig, D.Traficante, N.Fereday, S.Moore, S.Harrap, K.Sadkowsky, T.Pandeya, N.Hung, J.Malt, M.Alexander, B.Ashover, E.Brown, S.Corrish, T.Green, L.Jackman, L.Ferguson, K.Martin, K.Martyn, A.Ranieri, B.Mellon, A.Robertson, R.Vanden Bergh, T.Jones, M.Mackenzie, P.Maidens, J.Nattress, K.Chiew, Y. E.Stenlake, A.Sullivan, H.White, J.Jayde, VMamers, P.Bowes, L.Galletta, L.Giles, D.Hendley, J.Alsop, K.Ball, C.Young, C.Schmidt, T.Shirley, H.Viduka, S.Brooks, JuliaStuart-Harris, R.Kirsten, R.Rutovitz, J.Clingan, P.Glasgow, A.Proietto, A.Braye, S.Otton, G.Shannon, J.Bonaventura, T.Stewart, J.Begbie, S.Bell, D.Baron-Hay, S.Ferrier, A.Gard, G.Nevell, D.Pavialds, N.Valmadre, S.Young, B.Camaris, C.Crouch, R.Edwards, L.Hacker, N.Marsden, D.Robertson, G.Beale, P.Beith, J.Carter, J.Dalrymple, C.Houghton, R.Russell, P.Links, M.Grygiel, J.Hill, J.Brand, A.Byth, K.Jaworski, R.Sharma, R.Harnett, P.Wain, G.Friedlander, M.Ward, B.Papadimos, D.Crandon, A.Cummings, M.Horwood, K.Obermair, A.Perrin, L.Wyld, D.Nicklin, J.Davy, M.Oehler, M. K.Hall, C.Dodd, T.Healy, T.Pittman, K.Henderson, D.Miller, J.Pierdes, J.Blomfield, P.Challis, D.McIntosh, R.Parker, A.Brown, B.Rome, R.Allen, D.Grant, P.Hyde, S.Laurie, R.Robbie, M.Healy, D.Jobling, T.Manolitsas, T.McNealage, J.Rogers, P.Susil, B.Sumithran, E.Simpson, L.Phillips, K.Rischin, D.Fax, S.Johnson, D.Lade, S.Loughrey, M.O'Callaghan, N.Murray, W.Waring, P.Billson, VPyman, J.Neesham, D.Quinn, M.Underhill, C.Bell, R.Ng, L. F.Blum, R.Ganju, VHammond, L.Leung, Y.McCartney, A.Buck, M.Haviv, IPurdie, D.Whiteman, D.Zeps, N.Australian Ovarian Canc Study
JCO PRECISION ONCOLOGY; MAY 14 2018, 2 p1-p14, 14p.
Academic Journal
Kondrashova, O.Love, C.J.Lunke, S.Hsu, A.L.Waring, P.M.Taylor, G.R.Bowtell, D.Chenevix-Trench, G.Green, A.Webb, P.DeFazio, A.Gertig, D.Traficante, N.Fereday, S.Moore, S.Hung, J.Harrap, K.Sadkowsky, T.Pandeya, N.Malt, M.Mellon, A.Robertson, R.Vanden Bergh, T.Jones, M.Mackenzie, P.Maidens, J.Nattress, K.Chiew, Y.E.Stenlake, A.Sullivan, H.Alexander, B.Ashover, P.Brown, S.Corrish, T.Green, L.Jackman, L.Ferguson, K.Martin, K.Martyn, A.Ranieri, B.White, J.Jayde, V.Mamers, P.Bowes, L.Galletta, L.Giles, D.Hendley, J.Alsop, K.Schmidt, T.Shirley, H.Ball, C.Young, C.Viduka, S.Tran, H.Bilic, S.Glavinas, L.Brooks, J.Stuart-Harris, R.Kirsten, F.Rutovitz, J.Clingan, P.Glasgow, A.Proietto, A.Braye, S.Otton, G.Shannon, J.Bonaventura, T.Stewart, J.Begbie, S.Friedlander, M.Bell, D.Baron-Hay, S.Ferrier, A.Gard, G.Nevell, D.Pavlakis, N.Valmadre, S.Young, B.Camaris, C.Crouch, R.Edwards, L.Hacker, N.Marsden, D.Robertson, G.Beale, P.Beith, J.Carter, J.Dalrymple, C.Houghton, R.Russell, P.Links, M.Grygiel, J.Hill, J.Brand, A.Byth, K.Jaworski, R.Harnett, P.Sharma, R.Wain, G.Ward, B.Papadimos, D.Crandon, A.Cummings, M.Horwood, K.Obermair, A.Perrin, L.Wyld, D.Nicklin, J.Davy, M.Oehler, M.K.Hall, C.Dodd, T.Healy, T.Pittman, K.Henderson, D.Miller, J.Pierdes, J.Blomfield, P.Challis, D.McIntosh, R.Parker, A.Brown, B.Rome, R.Allen, D.Grant, P.Hyde, S.Laurie, R.Robbie, M.Healy, D.Jobling, T.Manolitsas, T.McNealage, J.Rogers, P.Susil, B.Sumithran, E.Simpson, I.Phillips, K.Rischin, D.Fox, S.Johnson, D.Lade, S.Loughrey, M.O'Callaghan, N.Murray, W.Waring, P.Billson, V.Pyman, J.Neesham, D.Quinn, M.Underhill, C.Bell, R.Ng, L.F.Blum, R.Ganju, V.Hammond, I.Leung, Y.McCartney, A.Buck, M.Haviv, I.Purdie, D.Whiteman, D.Zeps, N.
In: PLoS ONE. (PLoS ONE, 1 November 2015, 10(11))
Academic Journal
Gao, B.Emmanuel, C.Defazio, A.Harnett, P.Balleine, R.L.Russell, A.Henderson, M.Haber, M.Norris, M.Beesley, J.Chen, X.Q.Healey, S.Johnatty, S.E.Chenevix-Trench, G.Green, A.Webb, P.Moore, S.Harrap, K.Sadkowsky, T.Pandeya, N.Purdie, D.Whiteman, D.Malt, M.-R.Alexander, B.Ashover, P.Brown, S.Corrish, T.Green, L.Jackman, L.Ferguson, K.Martin, K.Martyn, A.Ranieri, B.Wong, M.Galletta, L.Bowtell, D.Traficante, N.Fereday, S.Phillips, K.Rischin, D.Fox, S.Johnson, D.Waring, P.Lade, S.Loughrey, M.O'Callaghan, N.Murray, W.Haviv, I.Bowes, L.Giles, D.Hendley, J.Alsop, K.Hung, J.Chiew, Y.-E.Gertig, D.Stuart-Harris, R.Kirsten, F.Rutovitz, J.Clingan, P.Glasgow, A.Proietto, A.Braye, S.Otton, G.Mellon, A.Robertson, R.Shannon, J.Bonaventura, T.Stewart, J.Begbie, S.Friedlander, M.Bell, D.Baron-Hay, S.Ferrier, A.Gard, G.Nevell, D.Pavlakis, N.Valmadre, S.Young, B.Maidens, J.Camaris, C.Crouch, R.Edwards, L.Hacker, N.Marsden, D.Robertson, G.Vanden Bergh, T.Jones, M.Mackenzie, P.Beale, P.Beith, J.Carter, J.Dalrymple, C.Hamilton, A.Houghton, R.Russell, P.Nattress, K.Links, M.Grygiel, J.Hill, J.Brand, A.Byth, K.Jaworski, R.Sharma, R.Achen, A.Wain, G.Stenlake, A.Sullivan, H.Ward, B.Papadimos, D.Crandon, A.Cummings, M.Horwood, K.Obermair, A.Perrin, L.Wyld, D.Nicklin, J.Davy, M.Oehler, M.K.Hall, C.Dodd, T.Healy, T.Pittman, K.White, J.Henderson, D.Miller, J.Pierdes, J.Blomfield, P.Challis, D.McIntosh, R.Parker, A.Jayde, V.Brown, B.Rome, R.Allen, D.Grant, P.Hyde, S.Laurie, R.Robbie, M.Healy, D.Jobling, T.Manolitsas, T.McNealage, J.Rogers, P.Susil, B.Sumithran, E.Simpson, I.Mamers, P.Billson, V.Pyman, J.Neesham, D.Quinn, M.Underhill, C.Bell, R.Ng, L.-F.Blum, R.Ganju, V.Hammond, I.Leung, Y.McCartney, A.Buck, M.Zeps, N.Schmidt, T.Shirley, H.Ball, C.Young, C.Viduka, S.Tran, H.Bilic, S.Glavinas, L.Brooks, J.
In: Scientific Reports. (Scientific Reports, 9 May 2014, 4)
Academic Journal
Pearce, C.L.Anderson, A.R.Wu, A.H.Near, A.M.Van Den Berg, D.J.Edlund, C.K.Ramus, S.J.Gayther, S.A.Gentry-Maharaj, A.Menon, U.Chen, X.Beesley, J.Webb, P.M.Spurdle, A.B.Chenevix-Trench, G.Gertig, D.Vanden Bergh, T.Camaris, C.Crouch, R.Edwards, L.Hacker, N.Marsden, D.Robertson, G.DeFazio, A.Hung, J.Chiew, Y.E.Stenlake, A.Sullivan, H.Brand, A.Jaworski, R.Harnett, P.Wain, G.Green, A.Moore, S.Harrap, K.Sadkowsky, T.Purdie, D.Whiteman, D.Alexander, B.Ashover, P.Brown, S.Corrish, T.Green, L.Jackman, L.Martin, K.Ranieri, B.White, J.Mamers, P.Healy, D.Jobling, T.Maniolitas, T.McNealage, J.Rogers, P.Susil, B.Veitch, A.Constable, J.Ping Tong, S.Robinson, I.Simpson, I.Schmidt, T.Shirley, H.Viduka, S.Tran, H.Bilic, S.Glavinas, L.Zeps, N.Mellon, A.Robertson, R.Proietto, A.Braye, S.Otton, G.Bonaventura, T.Stewart, J.Friedlander, M.Maidens, J.Bell, D.Baron-Hay, S.Ferrier, A.Gard, G.Nevell, D.Young, B.Nattress, K.Beale, P.Beith, J.Carter, J.Dalrymple, C.Hamilton, A.Houghton, R.Russell, P.Crandon, A.Cummings, M.Horwood, K.Obermair, A.Wyld, D.Nicklin, J.Perrin, L.Ward, B.Papadimos, D.Davy, M.Hall, C.Dodd, T.Healy, T.Pittman, K.Henderson, D.Hyde, S.Miller, J.Pierdes, J.Jayde, V.Blomfield, P.Challis, D.McIntosh, R.Parker, A.Brown, B.Rome, R.Allen, D.Grant, P.Hyde, S.Laurie, R.Robbie, M.Traficante, N.Fereday, S.Bowes, L.Phillips, K.Rischin, D.Waring, P.Loughrey, M.O'Callaghan, N.Murray, B.Haviv, I.Billson, V.Galloway, S.Pyman, J.Quinn, M.Hammond, I.McCartney, A.Leung, Y.Holt, S.K.Chen, C.Doherty, J.A.Rossing, M.A.Whittemore, A.S.McGuire, V.DiCioccio, R.A.Goodman, M.T.Lurie, G.Carney, M.E.Wilkens, L.R.Ness, R.B.Moysich, K.B.Edwards, R.Jennison, E.Kjaer, S.K.Hogdall, E.Hogdall, C.K.Goode, E.L.Vierkant, R.A.Cunningham, J.C.Sellers, T.A.Schildkraut, J.M.Moorman, P.G.Berchuck, A.Iversen, E.S.Cramer, D.W.Terry, K.L.Vitonis, A.F.Titus-Ernstoff, L.Song, H.Pharoah, P.D.P.Anton-Culver, H.Ziogas, A.Galitovskiy, V.Brewster, W.
In: British Journal of Cancer. (British Journal of Cancer, 27 January 2009, 100(2):412-420)
Academic Journal
Ramus, S.J.Gayther, S.A.Vierkant, R.A.Cunningham, J.M.Liebow, M.Goode, E.L.Johnatty, S.E.Webb, P.M.Chen, X.Beesley, J.Chenevix-Trench, G.Bowtell, D.Green, A.DeFazio, A.Gertig, D.Traficante, N.Moore, S.Hung, J.Fereday, S.Harrap, K.Sadkowsky, T.Mellon, A.Robertson, R.Vanden Bergh, T.Maidens, J.Nattress, K.Chiew, Y.E.Stenlake, A.Sullivan, H.Alexander, B.Ashover, P.Brown, S.Corrish, T.Green, L.Jackman, L.Martin, K.Ranieri, B.White, J.Jayde, V.Bowes, V.L.Mamers, P.Schmidt, T.Shirley, H.Viduka, S.Tran, H.Bilic, S.Glavinas, L.Proietto, A.Braye, S.Otton, G.Bonaventura, T.Stewart, J.Friedlander, M.Bell, D.Baron-Hay, S.Ferrier, A.Gard, G.Nevell, D.Young, B.Camaris, C.Crouch, R.Edwards, L.Hacker, N.Marsden, D.Robertson, G.Beale, P.Beith, J.Carter, J.Dalrymple, C.Hamilton, A.Houghton, R.Russell, P.Brand, A.Jaworski, R.Harnett, P.Wain, G.Crandon, A.Cummings, M.Horwood, K.Obermair, A.Wyld, D.Nicklin, J.Papadimos, D.Perrin, L.Ward, B.Davy, M.Hall, C.Dodd, T.Healy, T.Pittman, K.Henderson, D.Hyde, S.Miller, J.Pierdes, J.Blomfield, P.Challis, D.McIntosh, R.Parker, A.Brown, B.Rome, R.Allen, D.Grant, P.Laurie, R.Robbie, M.Healy, D.Jobling, T.Maniolitas, T.McNealage, J.Rogers, P.Susil, B.Veitch, A.Constable, J.Ping Tong, S.Robinson, I.Simpson, I.Phillips, K.Rischin, D.Waring, P.Loughrey, M.O'Callaghan, N.Murray, B.Billson, V.Galloway, S.Pyman, J.Quinn, M.Hammond, I.McCartney, A.Leung, Y.Haviv, I.Purdie, D.Whiteman, D.Zeps, N.Pike, M.C.Van Den Berg, D.J.Wu, A.H.Pearce, C.L.Menon, U.Gentry-Maharaj, A.DiCioccio, R.A.Moysich, K.B.McGuire, V.Whittemore, A.S.Song, H.Pharoah, P.D.P.Easton, D.F.Garcia-Closas, M.Chanock, S.Brinton, L.Lissowska, J.Terry, K.L.Cramer, D.W.Tworoger, S.S.Hankinson, S.E.Berchuck, A.Moorman, P.G.Schildkraut, J.M.Kjaer, S.K.Hogdall, E.Hogdall, C.Blaakaer, J.Ness, R.B.Edwards, R.P.Carney, M.E.Lurie, G.Goodman, M.T.Wang-Gohrke, S.Kropp, S.Chang-Claude, J.
In: International Journal of Cancer. (International Journal of Cancer, 15 July 2008, 123(2):380-388)
Academic Journal
Bowtell, D.Chenevix-Trench, G.Green, A.Webb, P.DeFazio, A.Gertig, D.Traficante, N.Fereday, S.Moore, S.Harrap, K.Sadkowsky, T.Hung, J.Vanden Bergh, T.Jones, M.Maidens, J.Nattress, K.Chiew, Y.E.Stenlake, A.Sullivan, H.Alexander, B.Ashover, P.Brown, S.Corrish, T.Green, L.Jackman, L.Martin, K.Ranieri, B.White, J.Jayde, V.Bowes, L.Mamers, P.Schmidt, T.Shirley, H.Viduka, S.Tran, H.Bilic, S.Glavinas, L.Hammond, I.McCartney, A.Leung, Y.Buck, M.Zeps, N.Stuart-Harris, R.Kirsten, F.Rutovitz, J.Clingan, P.Glasgow, A.Proietto, A.Braye, S.Otton, G.Shannon, J.Bonaventura, T.Stewart, J.Begbie, S.Friedlander, M.Bell, D.Baron-Hay, S.Ferrier, A.Gard, G.Nevell, D.Pavlakis, N.Young, B.Camaris, C.Crouch, R.Edwards, L.Hacker, N.Marsden, D.Robertson, G.Beale, P.Beith, J.Carter, J.Dalrymple, C.Hamilton, A.Houghton, R.Russell, P.Links, M.Grygiel, J.Hill, J.Brand, A.Byth, K.Jaworski, R.Harnett, P.Sharma, R.Wain, G.Purdie, D.Whiteman, D.Ward, B.Papadimos, D.Crandon, A.Cummings, M.Horwood, K.Obermair, A.Perrin, L.Wyld, D.Nicklin, J.Davy, M.Oehler, M.Hall, C.Dodd, T.Healy, T.Pittman, K.Henderson, D.Hyde, S.Miller, J.Pierdes, J.Blomfield, P.Challis, D.McIntosh, R.Parker, A.Brown, B.Rome, R.Allen, D.Grant, P.Hyde, S.Laurie, R.Robbie, M.Healy, D.Jobling, T.Manolitsas, T.McNealage, J.Rogers, P.Susil, B.Sumithran, E.Simpson, I.Haviv, I.Phillips, K.Rischin, D.Fox, S.Johnson, D.Waring, P.Loughrey, M.O'Callaghan, N.Murray, B.Billson, V.Pyman, J.Neesham, D.Quinn, M.Underhill, C.Bell, R.Ng, L.F.Blum, R.Ganju, V.Mellon, A.Robertson, R.Lose, F.Kay, G.F.Spurdle, A.B.Duffy, D.L.Kedda, M.A.
In: Journal of the National Cancer Institute. (Journal of the National Cancer Institute, November 2008, 100(21):1519-1529)
Academic Journal
Beesley, J.Jordan, S.J.Spurdle, A.B.Webb, P.M.Chenevix-Trench, G.Bowtell, D.Green, A.DeFazio, A.Gertig, D.Traficante, N.Moore, S.Hung, J.Fereday, S.Harrap, K.Sadkowsky, T.Mellon, A.Robertson, R.Vanden Bergh, T.Maidens, J.Nattress, K.Chiew, Y.E.Stenlake, A.Sullivan, H.Alexander, B.Ashover, P.Brown, S.Corrish, T.Green, L.Jackman, L.Martin, K.Ranieri, B.White, J.Jayde, V.Bowes, L.Mamers, P.Schmidt, T.Shirley, H.Viduka, S.Tran, H.Bilic, S.Glavinas, L.Proietto, A.Braye, S.Otton, G.Bonaventura, T.Stewart, J.Friedlander, M.Bell, D.Baron-Hay, S.Ferrier, A.Gard, G.Nevell, D.Young, B.Camaris, C.Crouch, R.Edwards, L.Hacker, N.Marsden, D.Robertson, G.Beale, P.Beith, J.Carter, J.Dalrymple, C.Hamilton, A.Houghton, R.Russell, P.Brand, A.Jaworski, R.Harnett, P.Wain, G.Crandon, A.Cummings, M.Horwood, K.Obermair, A.Wyld, D.Nicklin, J.Perrin, L.Ward, B.Davy, M.Hall, C.Dodd, T.Healy, T.Pittman, K.Henderson, D.Hyde, S.Miller, J.Pierdes, J.Blomfield, P.Challis, D.McIntosh, R.Parker, A.Brown, B.Rome, R.Allen, D.Grant, P.Laurie, R.Robbie, M.Healy, D.Jobling, T.Maniolitas, T.McNealage, J.Rogers, P.Susil, B.Veitch, A.Constable, J.Tong, S.P.Robinson, I.Simpson, I.Phillips, K.Rischin, D.Waring, P.Loughrey, M.O'Callaghan, N.Murray, B.Billson, V.Galloway, S.Pyman, J.Quinn, M.Hammond, I.McCartney, A.Leung, Y.Haviv, I.Purdie, D.Whiteman, D.Zeps, N.Song, H.Pharoah, P.D.P.Ramus, S.J.Gayther, S.A.Kjaer, S.K.Hogdall, E.DiCioccio, R.A.McGuire, V.Whittemore, A.S.
In: Cancer Epidemiology Biomarkers and Prevention. (Cancer Epidemiology Biomarkers and Prevention, 1 December 2007, 16(12):2557-2565)
Academic Journal
Patch AM; 1] Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia [2] QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.; Christie EL; Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.; Etemadmoghadam D; 1] Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia [2] Department of Pathology, University of Melbourne, Parkville, Victoria 3052, Australia [3] Sir Peter MacCallum Cancer Centre Department of Oncology, University of Melbourne, Parkville, Victoria 3052, Australia.; Garsed DW; Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.; George J; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut 06030, USA.; Fereday S; Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.; Nones K; 1] Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia [2] QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.; Cowin P; Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.; Alsop K; Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.; Bailey PJ; 1] Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia [2] WolfsonWohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK.; Kassahn KS; 1] Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia [2] Technology Advancement Unit, Genetics and Molecular Pathology, SA Pathology, Adelaide, South Australia 5000, Australia.; Newell F; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia.; Quinn MC; 1] Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia [2] QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.; Kazakoff S; 1] Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia [2] QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.; Quek K; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia.; Wilhelm-Benartzi C; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London W12 0HS, UK.; Curry E; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London W12 0HS, UK.; Leong HS; Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.; Hamilton A; 1] Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia [2] Department of Medicine, University of Melbourne, Parkville, Victoria 3052, Australia [3] The Royal Women's Hospital, Parkville, Victoria 3052, Australia.; Mileshkin L; 1] Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia [2] Sir Peter MacCallum Cancer Centre Department of Oncology, University of Melbourne, Parkville, Victoria 3052, Australia.; Au-Yeung G; Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.; Kennedy C; Centre for Cancer Research, University of Sydney at Westmead Millennium Institute, and Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales 2145, Australia.; Hung J; Centre for Cancer Research, University of Sydney at Westmead Millennium Institute, and Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales 2145, Australia.; Chiew YE; Centre for Cancer Research, University of Sydney at Westmead Millennium Institute, and Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales 2145, Australia.; Harnett P; Crown Princess Mary Cancer Centre and University of Sydney at Westmead Hospital, Westmead, Sydney, New South Wales 2145, Australia.; Friedlander M; Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales 2031, Australia.; Quinn M; The Royal Women's Hospital, Parkville, Victoria 3052, Australia.; Pyman J; The Royal Women's Hospital, Parkville, Victoria 3052, Australia.; Cordner S; Victorian Institute of Forensic Medicine, Southbank, Victoria 3006, Australia.; O'Brien P; Victorian Institute of Forensic Medicine, Southbank, Victoria 3006, Australia.; Leditschke J; Victorian Institute of Forensic Medicine, Southbank, Victoria 3006, Australia.; Young G; Victorian Institute of Forensic Medicine, Southbank, Victoria 3006, Australia.; Strachan K; Victorian Institute of Forensic Medicine, Southbank, Victoria 3006, Australia.; Waring P; Department of Pathology, University of Melbourne, Parkville, Victoria 3052, Australia.; Azar W; Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.; Mitchell C; Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.; Traficante N; Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.; Hendley J; Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.; Thorne H; Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.; Shackleton M; 1] Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia [2] Sir Peter MacCallum Cancer Centre Department of Oncology, University of Melbourne, Parkville, Victoria 3052, Australia.; Miller DK; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia.; Arnau GM; Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.; Tothill RW; 1] Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia [2] Sir Peter MacCallum Cancer Centre Department of Oncology, University of Melbourne, Parkville, Victoria 3052, Australia.; Holloway TP; Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.; Semple T; Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.; Harliwong I; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia.; Nourse C; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia.; Nourbakhsh E; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia.; Manning S; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia.; Idrisoglu S; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia.; Bruxner TJ; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia.; Christ AN; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia.; Poudel B; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia.; Holmes O; 1] Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia [2] QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.; Anderson M; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia.; Leonard C; 1] Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia [2] QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.; Lonie A; Victorian Life Sciences Computation Initiative, Carlton, Victoria 3053, Australia.; Hall N; La Trobe Institute for Molecular Science, Bundoora, Victoria 3083, Australia.; Wood S; 1] Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia [2] QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.; Taylor DF; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia.; Xu Q; 1] Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia [2] QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.; Fink JL; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia.; Waddell N; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia.; Drapkin R; Dana-Farber Cancer Institute, Boston, Massachusetts 02115-5450, USA.; Stronach E; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London W12 0HS, UK.; Gabra H; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London W12 0HS, UK.; Brown R; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London W12 0HS, UK.; Jewell A; University of Chicago, Chicago, Illinois 60637, USA.; Nagaraj SH; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia.; Markham E; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia.; Wilson PJ; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia.; Ellul J; Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.; McNally O; Centre for Cancer Research, University of Sydney at Westmead Millennium Institute, and Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales 2145, Australia.; Doyle MA; Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.; Vedururu R; Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.; Stewart C; The University of Western Australia, Crawley, Western Australia 6009, Australia.; Lengyel E; University of Chicago, Chicago, Illinois 60637, USA.; Pearson JV; 1] Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia [2] QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.; Waddell N; 1] Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia [2] QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.; deFazio A; Centre for Cancer Research, University of Sydney at Westmead Millennium Institute, and Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales 2145, Australia.; Grimmond SM; 1] Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4067, Australia [2] WolfsonWohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK.; Bowtell DD; 1] Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia [2] Department of Pathology, University of Melbourne, Parkville, Victoria 3052, Australia [3] Sir Peter MacCallum Cancer Centre Department of Oncology, University of Melbourne, Parkville, Victoria 3052, Australia [4] Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London W12 0HS, UK [5] Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria 3052, Australia.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Academic Journal
Hedditch EL; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Gao B; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Russell AJ; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Lu Y; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Emmanuel C; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Beesley J; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Johnatty SE; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Chen X; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Harnett P; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; George J; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Williams RT; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Flemming C; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Lambrechts D; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Despierre E; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Lambrechts S; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Vergote I; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Karlan B; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Lester J; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Orsulic S; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Walsh C; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Fasching P; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Beckmann MW; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Ekici AB; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Hein A; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Matsuo K; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Hosono S; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Nakanishi T; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Yatabe Y; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Pejovic T; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Bean Y; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Heitz F; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Harter P; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; du Bois A; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Schwaab I; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Hogdall E; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Kjaer SK; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Jensen A; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Hogdall C; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Lundvall L; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Engelholm SA; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Brown B; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Flanagan J; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Metcalf MD; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Siddiqui N; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Sellers T; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Fridley B; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Cunningham J; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Schildkraut J; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Iversen E; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Weber RP; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Berchuck A; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Goode E; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Bowtell DD; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Chenevix-Trench G; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; deFazio A; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Norris MD; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; MacGregor S; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Haber M; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De; Henderson MJ; Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De
Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Corrish, T
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어